GZMB and tuberculosis: Additionally, previous studies have demonstrated that immune markers such as GZMB and soluble TRAILR can predict treatment outcomes during the intensive phase of tuberculosis (52), which also reflects the potential of the characteristic genes identified in this study for monitoring disease progression or treatment response.